The registration link is now ready for the brand new CCBIO course: “CANCER-RELATED VASCULAR BIOLOGY”.
Thorough understanding of general and cancer-related vascular biology is regarded important to understand processes like cancer growth, sustainability and progression, and is suggested to be a relevant target for therapy in various diseases. Through this new three-week course set up as part of the CCBIO/Harvard INTPART partnership between the Vascular Biology Program at Boston Children’s Hospital and CCBIO, the participants will meet and discuss with international experts who have been in the frontline of vascular biology research for decades.
Some of the topics that will be covered: Basics of vascular biology; vascular biology related therapeutic approaches; biomarkers in vascular biology – from discovery to clinical application; lymphangiogenesis and vascular biology in non-cancerous diseases. Complete program will soon be announced on this web page, where you also can find more information.
The course is open for all interested, such as Master students, undergraduate students of the Medical Research Program, PhD students, postdocs, researchers and technicians.
(The course is currently awaiting approval as a 10 ECTS course). Priority will be given to undergraduate students in case of fully booked only. No course fee.
The course runs three separate weeks this fall, with a mix of lectures, discussions and assignments:
Course week 1: September 17-21
Course week 2: October 1-5
Course week 3: November 12-16
Research seminars by the Harvard faculty which are part of the course, will also be open to audience not following the complete course. Separate information will be issued of these when date/time and abstracts are available.
If you have any questions, please contact the Bergen course coordinator Elisabeth.email@example.com